Journal Of Pathology

Journal Of Pathology英文簡介

The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease.

The Journal welcomes investigative studies on human tissues, in vitro and in vivo experimental studies, and investigations based on animal models with a clear relevance to human disease, including transgenic systems. In general, hypothesis driven studies that appropriately employ multiple investigative techniques are preferred over those that rely on a single methodology.

As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles, commentaries and perspectives and other features, both contributed and solicited.

Purely descriptive papers on diagnostic pathology (including case reports and prognostic papers without mechanistic and experimental insights) are not considered central to the Journal’s purpose. Correspondence relating to papers published in the Journal will be considered, but only if of general interest. Such correspondance may be published in online versions only, at the Editor's discretion.

In determining content, the primary considerations are excellence, relevance and novelty. As the journal of The Pathological Society, it seeks to reflect the broad scientific interests of the Society’s membership but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature.

Journal Of Pathology中文簡介

《Journal Of Pathology》是一本由WILEY出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于1969年，刊期Monthly，該刊已被國際權威數(shù)據庫SCIE、SCI收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 1區(qū)，小類學科：病理學 1區(qū)；腫瘤學 2區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q1。該刊發(fā)文范圍涵蓋腫瘤學等領域，旨在及時、準確、全面地報道國內外腫瘤學工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為9.883，平均審稿速度一般,3-8周。

中科院分區(qū)最新升級版（當前數(shù)據版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	1區(qū)	PATHOLOGY 病理學 ONCOLOGY 腫瘤學	1區(qū) 2區(qū)	是	否

中科院分區(qū)最新基礎版（當前數(shù)據版本：2021年12月最新基礎版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	2區(qū)	ONCOLOGY 腫瘤學 PATHOLOGY 病理學	2區(qū) 1區(qū)	是	否

中科院JCR分區(qū)歷年趨勢圖

JCR分區(qū)（當前數(shù)據版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q1	ONCOLOGY	Q1	9.883
	PATHOLOGY	Q1

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
9.883	168	38.77%	82.11%	未開放	一般,3-8周

IF值(影響因子)趨勢圖